Trademark: 88073891
Status Date
Tuesday, April 2, 2019
Registration Number
5713814
Registration Date
Tuesday, April 2, 2019
Filing Date
Friday, August 10, 2018
Published for Opposition
Tuesday, January 15, 2019
5 Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas
Apr 2, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 3, 2023
Assignment Of Ownership Not Updated Automatically
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2021
Teas Change Of Correspondence Received
May 6, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2021
Teas Change Of Correspondence Received
Apr 16, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 16, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2021
Teas Change Of Owner Address Received
Apr 2, 2019
Registered-Principal Register
Jan 15, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 15, 2019
Published For Opposition
Dec 26, 2018
Notification Of Notice Of Publication E-Mailed
Dec 3, 2018
Approved For Pub - Principal Register
Nov 28, 2018
Assigned To Examiner
Aug 18, 2018
New Application Office Supplied Data Entered
Aug 14, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
